Validation of high-risk HPV tests for primary cervical screeningMEIJER, C. J. L. M; BERKHOF, H; HEIDEMAN, D. A. M et al.Journal of clinical virology. 2009, Vol 46, issn 1386-6532, S1-S4, SUP3Article

Ethical analysis of HPV vaccine policy optionsZIMMERMAN, Richard K.Vaccine. 2006, Vol 24, Num 22, pp 4812-4820, issn 0264-410X, 9 p.Article

Intratype Variations of HPV 31 and 58 in Italian Women With Abnormal Cervical CytologyCENTO, Valeria; RAHMATALLA, Noor; CICCOZZI, Massimo et al.Journal of medical virology. 2011, Vol 83, Num 10, pp 1752-1761, issn 0146-6615, 10 p.Article

Anal HPV genotypes and related displasic lesions in Italian and foreign born high-risk malesORLANDO, Giovanna; BERETTA, Rosangela; FASOLO, M. Michela et al.Vaccine. 2009, Vol 27, issn 0264-410X, A24-A29, SUP1Conference Paper

Analytical performance of RNA isolated from BD SurePath^™ cervical cytology specimens by the PreTect^™ HPV-Proofer assayDIXON, Eric P; GRØNN, Petter; MALINOWSKI, Douglas P et al.Journal of virological methods. 2012, Vol 185, Num 2, pp 199-203, issn 0166-0934, 5 p.Article

Monitoring HPV vaccinationSTANLEY, Margaret; VILLA, Luisa Lina.Vaccine. Supplement. 2008, Vol 26, Num 1, issn 1359-5938, A24-A27Article

Comparison of AMPLICOR® and Hybrid Capture II® assays for high risk HPV detection in normal and abnormal liquid-based cytology : Use of INNO-LiPA Genotyping assay to screen the discordant resultsMO, L. Z; MONNIER-BENOIT, S; KANTELIP, B et al.Journal of clinical virology. 2008, Vol 41, Num 2, pp 104-110, issn 1386-6532, 7 p.Article

Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States—Do we need a broader vaccine policy?OSAZUWA-PETERS, N.Vaccine. 2013, Vol 31, Num 47, pp 5500-5505, issn 0264-410X, 6 p.Article

Profil anatomiclinique et virologique de l'adénocarcinome du col utérinHMISSA, S; MISSAOUI, N; LANDOLSI, H et al.MHA (Sousse). 2006, Vol 18, Num 53, pp 77-80, issn 0330-8030, 4 p.Article

Effect of Second Pregnancy on Maternal Carriage and Outcome of High-Risk Human Papillomavirus (HPV) : Experience from the Prospective Finnish Family HPV StudySARKOLA, Marja E; GRENMAN, Seija E; RINTALA, Marjut A. M et al.Gynecologic and obstetric investigation. 2009, Vol 67, Num 3, pp 208-216, issn 0378-7346, 9 p.Article

Rate of detection of high-risk HPV with two assays in women > 30 years of ageQUIGLEY, Neil B; POTTER, Nicholas T; CHIVUKULA, Mamatha et al.Journal of clinical virology. 2011, Vol 52, Num 1, pp 23-27, issn 1386-6532, 5 p.Article

HPV vaccine introduction in industrialized countriesWRIGHT, Thomas C; VAN DAMME, Pierre; SCHMITT, Heinz-Josef et al.Vaccine. Supplement. 2006, Vol 24, Num 3, issn 1359-5938, S3.122-S3.131Article

How much will it hurt? HPV vaccine side effects and influence on completion of the three-dose regimenREITER, Paul L; BREWER, Noel T; GOTTLIEB, Sami L et al.Vaccine. 2009, Vol 27, Num 49, pp 6840-6844, issn 0264-410X, 5 p.Article

p53 Polymorphism at codon 72 is not a risk factor for cervical carcinogenesis in central ItalyCENCI, Maria; FRENCH, Deborah; PISANI, Tiziana et al.Anticancer research. 2003, Vol 23, Num 2B, pp 1385-1387, issn 0250-7005, 3 p.Article

Human Papillomavirus Molecular Testing in Women with Low Grade Cervical Lesions: Experience from an Italian HospitalPABA, Pierpaolo; ASCONE, Chiara; CRISCUOLO, Anna Angela et al.Anticancer research. 2012, Vol 32, Num 4, pp 1253-1257, issn 0250-7005, 5 p.Article

High level of HPV 16 and 18 DNA load in anal swabs from male and female HIV-1 infected patientsPOIZOT-MARTIN, Isabelle; HENRY, Mireille; BENHAIM, Serge et al.Journal of clinical virology. 2009, Vol 44, Num 4, pp 314-317, issn 1386-6532, 4 p.Article

Population-based evaluation of type-specific HPV prevalence among women in British Columbia, CanadaOGILVIE, G. S; COOK, D. A; TAYLOR, D. L et al.Vaccine. 2013, Vol 31, Num 7, pp 1129-1133, issn 0264-410X, 5 p.Article

Epidemiology and genotype distribution of human papillomavirus (HPV) in women of Sardinia (Italy)MASIA, Giuseppina; PAOLA MAZZOLENI, Anna; CONTU, Graziella et al.Vaccine. 2009, Vol 27, issn 0264-410X, A11-A16, SUP1Conference Paper

DNA vaccines against HPV-16 E7-expressing tumour cellsDE MARCO, Federico; HALLEZ, Sophie; BRULET, Jean Marc et al.Anticancer research. 2003, Vol 23, Num 2B, pp 1449-1454, issn 0250-7005, 6 p.Article

A summary of the post-licensure surveillance initiatives for GARDASIL/SILGARD^®BONANNI, Paolo; COHET, Catherine; KJAER, Susanne K et al.Vaccine. 2010, Vol 28, Num 30, pp 4719-4730, issn 0264-410X, 12 p.Article

HPV vaccine use in the developing worldKANE, Mark A; SHERRIS, Jacqueline; COURSAGET, Pierre et al.Vaccine. Supplement. 2006, Vol 24, Num 3, issn 1359-5938, S3.132-S3.139Article

Interaction between the HPV E7 oncoprotein and the transcriptional coactivator p300BERNAT, Agnieszka; AVVAKUMOV, Nikita; MYMRYK, Joe S et al.Oncogene (Basingstoke). 2003, Vol 22, Num 39, pp 7871-7881, issn 0950-9232, 11 p.Article

Automation of the linear array HPV genotyping test and its application for routine typing of human papillomaviruses in cervical specimens of women without cytological abnormalities in SwitzerlandDOBEC, Marinko; BANNWART, Fridolin; KAEPPELI, Franz et al.Journal of clinical virology. 2009, Vol 45, Num 1, pp 23-27, issn 1386-6532, 5 p.Article

Comparison of the PapilloCheck^® Assay With the Digene HC2 HPV DNA Assay for the Detection of 13 High-Risk Human Papillomaviruses in Cervical and Anal ScrapesDIDELOT, Marie-Noelle; BOULLE, Nathalie; DAMAY, Audrey et al.Journal of medical virology. 2011, Vol 83, Num 8, pp 1377-1382, issn 0146-6615, 6 p.Article

Psychosocial aspects of vaccine acceptabilityZIMET, Gregory D; LIDDON, Nicole; ROSENTHAL, Susan L et al.Vaccine. Supplement. 2006, Vol 24, Num 3, issn 1359-5938, S3.201-S3.209Article